Completed PHASE4 INTERVENTIONAL 2-arm NCT00531713

Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism (T4-T3)

Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism,a Double Blind Randomized Cross-Over Study.

Sponsor: Copenhagen University Hospital at Herlev

Conditions Depression Quality of Life

Interventions Triiodothyronine

Updated 4 times since 2017 Last updated: Sep 18, 2007 Started: Apr 30, 2003 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00531713, this PHASE4 trial focuses on Depression and Quality of Life and remains completed. Sponsored by Copenhagen University Hospital at Herlev, it has been updated 4 times since 2003, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jan 2017 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Copenhagen University Hospital at Herlev

Data source: Copenhagen University Hospital at Herlev

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Herlev, Denmark